GOLGA8A repeat expansion redefines the genetic architecture of aFTLD-U

References

[1] Urso D,Brayne C,Logroscino G.Incidence and prevalence of frontotemporal dementia: a systematic review and meta-analysis.JAMA Neurol2025;82:1144 PMCID:PMC12418226

[2] Chu M,Liu L.Clinical, genetic, and pathological features of very early onset frontotemporal lobe degeneration: a systematic review.Curr Alzheimer Res2023;19:870-7

[3] Van Langenhove T,Van Broeckhoven C.The molecular basis of the frontotemporal lobar degeneration-amyotrophic lateral sclerosis spectrum.Ann Med2012;44:817-28 PMCID:PMC3529157

[4] Mackenzie IRA,Kusaka H.Distinct pathological subtypes of FTLD-FUS.Acta Neuropathol2010;121:207-18

[5] De Coster W,Baker M.A repeat expansion in GOLGA8A is a major risk factor for atypical frontotemporal lobar degeneration with ubiquitin-positive inclusions.Nat Genet2026;58:726-36

[6] Rademakers R,Mackenzie IR.Advances in understanding the molecular basis of frontotemporal dementia.Nat Rev Neurol2012;8:423-34 PMCID:PMC3629543

[7] Kovacs G.Molecular pathological classification of neurodegenerative diseases: turning towards precision medicine.Int J Mol Sci2016;17:189 PMCID:PMC4783923

[8] Rajan-Babu I,Eberle MA.Sequence composition changes in short tandem repeats: heterogeneity, detection, mechanisms and clinical implications.Nat Rev Genet2024;25:476-99

[9] Malik I,Wang ET.Molecular mechanisms underlying nucleotide repeat expansion disorders.Nat Rev Mol Cell Biol2021;22:589-607

[10] Gendron TF.Disease mechanisms of C9ORF72 repeat expansions.Cold Spring Harb Perspect Med2018;8:a024224 PMCID:PMC5880161

[11] Boivin M,Pfister V.Translation of GGC repeat expansions into a toxic polyglycine protein in NIID defines a novel class of human genetic disorders: the polyG diseases.Neuron2021;109:1825-35.e5 PMCID:PMC8186563

[12] Mackenzie IR.FET proteins in frontotemporal dementia and amyotrophic lateral sclerosis.Brain Res2012;1462:40-3

[13] Carey JL.Liquid-liquid phase separation of TDP-43 and FUS in physiology and pathology of neurodegenerative diseases.Front Mol Biosci2022;9:826719 PMCID:PMC8847598

[14] Antonacci F,Huddleston J.Palindromic GOLGA8 core duplicons promote chromosome 15q13.3 microdeletion and evolutionary instability.Nat Genet2014;46:1293-302 PMCID:PMC4244265

[15] Mcdonnell EI,Goldman J.Age of onset of huntington's disease in carriers of reduced penetrance alleles.Mov Disord2021;36:2958-61 PMCID:PMC8688195

[16] Kampmann M.Molecular and cellular mechanisms of selective vulnerability in neurodegenerative diseases.Nat Rev Neurosci2024;25:351-71

[17] Shepherd R,Pang K,Novakovic B.Sexual dimorphism in innate immunity: the role of sex hormones and epigenetics.Front Immunol2021;11:604000 PMCID:PMC7873844

[18] Vegeto E,Della Torre S.The role of sex and sex hormones in neurodegenerative diseases.Endocr Rev2020;41:273-319 PMCID:PMC7156855

[19] Hampel H,Cummings J.The foundation and architecture of precision medicine in neurology and psychiatry.Trends Neurosci2023;46:176-98 PMCID:PMC10720395

[20] Gall-Duncan T,Yuen RK.Advancing genomic technologies and clinical awareness accelerates discovery of disease-associated tandem repeat sequences.Genome Res2022;32:1-27 PMCID:PMC8744678

[21] Zhou Z,Ashizawa T.Neurodegenerative diseases associated with non-coding CGG tandem repeat expansions.Nat Rev Neurol2022;18:145-57

[22] Trigiante G,Cerase A.Emerging roles of repetitive and repeat-containing RNA in nuclear and chromatin organization and gene expression.Front Cell Dev Biol2021;9:735527 PMCID:PMC8552494

[23] Zhang Y,Li Z.Advances on the mechanisms and therapeutic strategies in non-coding CGG repeat expansion diseases.Mol Neurobiol2024;61:10722-35

[24] Hammond SM,Alves S.Delivery of oligonucleotide-based therapeutics: challenges and opportunities.EMBO Mol Med2021;13:e13243 PMCID:PMC8033518

[25] Tanudisastro HA,Dashnow H.Sequencing and characterizing short tandem repeats in the human genome.Nat Rev Genet2024;25:460-75

[26] Logsdon GA,Eichler EE.Long-read human genome sequencing and its applications.Nat Rev Genet2020;21:597-614 PMCID:PMC7877196